Filing Details

Accession Number:
0000902664-22-002740
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-02 19:44:18
Reporting Period:
2022-04-28
Accepted Time:
2022-05-02 19:44:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1162194 Standard Biotools Inc. LAB Laboratory Analytical Instruments (3826) 770513190
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1727492 Caligan Partners Lp 590 Madison Avenue
New York NY 10022
No No Yes No
1785557 Edward David Johnson 590 Madison Avenue
New York NY 10022
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share ("Common Stock") Acquisiton 2022-04-28 27,600 $2.40 9,112,438 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-04-29 247,400 $2.66 9,359,838 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-05-02 125,000 $2.81 9,484,838 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Footnotes
  1. Price is the volume weighted average selling price of all sales by Caligan Partners LP ("Caligan") and David Johnson (together with Caligan, the "Reporting Persons") on the transaction date for prices ranging from $2.37 to $2.44.
  2. The securities reported herein are held by an affiliated fund and managed account of Caligan. David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
  3. Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date for prices ranging from $2.57 to $2.70.
  4. Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date for prices ranging from $ 2.71 to $2.89.
  5. The Reporting Persons hereby undertake to provide upon request of the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.